Market research

CMRA Comera Life Sciences Holdings Inc

PINK USD Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts

Market cap: 682K
P/E ratio: Not available
Analyst target: Not available
Dividend yield: Not available
Beta: 0.04

Loading price history…

Profile

Company facts

Exchange: PINK
Currency: USD
Sector: Healthcare
Industry: Biotechnology
ISIN: US20037C1080
Market cap: 682K
P/E ratio: Not available
Analyst target: Not available
Dividend yield: Not available
Beta: 0.04

About

About Comera Life Sciences Holdings Inc

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. The company's lead pipeline candidate is CLS-001, a subcutaneous formulation of vedolizumab for the treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

Visit company website

Reported results

Fundamentals

Open this section to load reported financial history.

Annual returns

No comments yet

Start a focused discussion about CMRA.

CMRA Comera Life Sciences Holdings Inc

Price & volume

Company facts

About Comera Life Sciences Holdings Inc

Fundamentals

Earnings

Cash flow

Profitability

Valuation

Performance

Annual returns

Investor discussion

No comments yet